Search
for
Sort by
Research 91–120 of 1000+
- Common Dermatologic Conditions
- Vitamins
- S4890 Infliximab-Induced Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis Syndrome
- Granzyme B in Autoimmune Skin Disease
- Off-label uses of retinoids in dermatology
- Scalp condition impacts hair growth and retention via oxidative stress
- Intense Pulsed Light: From the Past to the Future
- Cyclosporine-induced alopecia:a case report, FDA adverse event reporting system analysis and literature assessment
- Epidermal stem cells: skin surveillance and clinical perspective
- RASopathic alopecia: Hair changes associated with vemurafenib therapy
- Efficacy of tofacitinib in pediatric alopecia universalis
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- The case for case reports
- Neuroimaging of sleep and depression
- Increased Incidence of Telogen Effluvium Following Platelet-Rich Plasma Therapy in Patients with Elevated TNF-α Expression: A Prospective Cohort Study
- Clinical and biological impact of the exposome on the skin
- The concealed side of caspases: beyond a killer of cells
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Alopecia areata – hyperactivity of the hypothalamic–pituitary–adrenal axis is a myth?
- Autoimmune thyroid disease and human health: a systematic review of Mendelian randomization studies
- Androgenic Alopecia: Cross-Talk Between Cell Signal Transduction Pathways
- Alopecia Areata Associated with Dupilumab: A Case Report and Literature Review
- Concentric or Targetoid Regrowth in Alopecia Areata
- Hairy Math: Addition of Wnt-3a to Multiply Bulge Cells
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- HAIR REGROWTH
- Hair loss
- Cutaneous Crohn's disease treated with infliximab and 4 years of follow up
- Nanotechnological reprogramming of the pathological skin microenvironment in scar formation and atopic dermatitis